When was NeoGenomics founded?

NeoGenomics was founded in 2002 and raised its 1st funding round 7 years after it was founded.

Where is NeoGenomics located?

NeoGenomics is headquartered in Fort Myers, United States. It is registered at Fort Myers, Florida.

How many employees does NeoGenomics have?

As of May 31, 2026, the latest employee count at NeoGenomics is 1770.

Is NeoGenomics a funded company?

NeoGenomics is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Mar 30, 2009.

When was the latest funding round of NeoGenomics?

NeoGenomics' latest funding was a $***** Post IPO round on Jan 20, 2021, with participation from 0 investor.

What is the annual revenue of NeoGenomics?

Annual revenue of NeoGenomics is between $500M and $1B as on Dec 31, 2025

Where does NeoGenomics rank among its competitors?

NeoGenomics ranks 17th amongst 539 active competitors, of which 165 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Delfi Diagnostics, which secured $34.3M in Dec, 2025.

Who are the top competitors of NeoGenomics?

NeoGenomics' top competitors include Guardant Health, Natera and Myriad Genetics. Among them, Delfi Diagnostics secured the most recent funding round in December, 2025.

NeoGenomics - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of cancer genetic diagnostic services. The company operates a network of cancer-focused testing labs, which is engaged in providing testing services to pathologists, oncologists, and other laboratories. The company provides services for cancer cytogenetics, hematologic and solid tumor FISH testing, 10-color flow cytometry, and nearly 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry.

Website: www.neogenomics.com/
Social
Email ID: *****@neogenomics.com
Phone Number: +1 **********
Registered Address: Fort Myers, Florida

Key Metrics

Founded Year

2002

Location

Fort Myers, United States

Stage

Public

Latest Funding Round

Post IPO, Jan 20, 2021, $*****

Investors

Ranger Investments & 2 more

Ranked

17^th among 539 active competitors

Annual Revenue

$500M - $1B as on Dec 31, 2025

Employee Count

1,770 as on May 31, 2026

Investment & Acquisitions

Pathline & 10 more

Similar Companies

Guardant Health & 682 more

Exit Details

Public

View NeoGenomics' full profile

NeoGenomics is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NEOGENOMICS INC CIN: 1077183 , United States, Active	Oct 07, 2018	$500M - $1B (As on Dec 31, 2025)	2100 (As on Dec 31, 2023)	-
Neogenomics Laboratories, Inc. CIN: 001t000000WoV9sAAF , United States, Active	Mar 09, 2020	-	-	-
Neogenomics Laboratories, Inc. CIN: 593725585 , United States, Active	Dec 26, 999	-	2146 (As on Dec 31, 2024)	-

NeoGenomics got listed on Nov 02, 1999.

Click here to take a look at NeoGenomics's IPO in detail

NeoGenomics has raised funding over 3 rounds. Its first funding round was on Mar 30, 2009. NeoGenomics has 3 institutional investors.

Here is the list of recent funding rounds of NeoGenomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 20, 2021	4060987	Post IPO	2314591	4547905	4897097	1969546
Jun 27, 2019	3525544	Conventional Debt	1000697	2619058	6404125	7914879
Mar 30, 2009	1075195	Post IPO	1929836	9672295	6880895	5121373

Access funding benchmarks and valuations. Sign up today!

View details of NeoGenomics's funding rounds and investors

NeoGenomics' employee count trend

NeoGenomics has 1,770 employees as of May 26. Here is NeoGenomics's employee count trend over the years:

Uncover NeoGenomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeoGenomics include Guardant Health, Natera and Myriad Genetics. Here is the list of Top 10 competitors of NeoGenomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	Khosla Ventures, Orbimed & 25 others	79/100
2nd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Foresite Capital & 17 others	77/100
3rd	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, TriplePoint Capital & 6 others	72/100
4th	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Deerfield, Casdin Capital & 11 others	71/100
5th	Exact Sciences 1995, Madison (United States), Acquired	Provider of non-invasive molecular diagnostic testing solutions for cancer	-	Petrillo Capital, Back Bay Group & 8 others	71/100
6th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Braidwell & 19 others	70/100
7th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Beyond Ventures, Ping An Ventures & 21 others	70/100
8th	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 31 others	69/100
9th	Delfi Diagnostics 2019, Baltimore (United States), Series B	Provider of DNA sequencing for cancer detection	$332M	Merck Global Health Innovation Fund, DFJ Growth ... & 19 others	68/100
10th	Geneoscopy 2015, St. Louis (United States), Series C	Developer of non-invasive biomarker tests for colorectal cancer	$219M	LightChain Capital, Cultivation Capital & 18 others	67/100
17th	NeoGenomics 2002, Fort Myers (United States), Public	Provider of cancer genetic diagnostic services	-	Ranger Investments, Aspen Capital & 1 others	63/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on NeoGenomics's competitors? Click here to see the top ones

NeoGenomics has made 1 investments in companies including Inivata. NeoGenomics has also acquired 10 companies including Pathline and Inivata.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Mar 10, 2025	Acquisition	Pathline	2009	Ramsey (United States)
May 05, 2021	Acquisition	Inivata	2014	Cambridge (United Kingdom)
Mar 24, 2021	Acquisition	Trapelo	2009	Fort Myers (United States)